Influence of the Elipse Intragastric Balloon on Obesity and Metabolic Profile

Ramai, Daryl; Singh, Jameel; Mohan, Babu P.; Madedor, Ogenetega; Brooks, Olivia W.; Barakat, Mohamed; Ofosu, Andrew; Khan, Shahab R.; Chandan, Saurabh; Dhindsa, Banreet; Dhaliwal, Amaninder; Facciorusso, Antonio; McDonough, Stephanie

doi:10.1097/mcg.0000000000001484

Cited by 18 publications

(10 citation statements)

References 35 publications

(85 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…doi: http://dx.doi.org/10.47892/rgp.2022.423.1345 probó ser tolerable y con un mayor perfil de seguridad en comparación a otros dispositivos similares; dentro de los efectos adversos descritos son el dolor abdominal (37,5%), vómitos (26,9%), diarrea (15,4%) y obstrucción del intestino delgado (0,5%), aunque no se describieron casos de pancreatitis (12) . Dentro del resto de modalidades de balón intragástrico, las complicaciones más comunes asociadas son: dolor abdominal, obstrucción del tracto de salida gástrico, náuseas, vómitos recurrentes, erosión esofágica y gástrica, perforación gástrica, neumonía y laringoespasmo.…”

Section: Discussionunclassified

Pancreatitis aguda asociada a balón intragástrico

Vega

Cabrera-Hinojosa

2023

Rev Gastroenterol Peru

View full text Add to dashboard Cite

Presentamos el caso de una mujer joven con el hábito de dormir en posición decúbito ventral, quien refiere que, tras la colocación de balón intragástrico, inició cuadros repetitivos de dolor abdominal en epigastrio, de aparición nocturna. El más reciente se caracterizó por dolor abdominal súbito e intenso, elevación de enzimas pancreáticas y hallazgos imagenológicos compatibles con pancreatitis aguda. Tras realizar un estudio etiológico sistemático, se descartan otras causas, retirándose el balón intragástrico con inmediato cese de los dolores nocturnos. Se atribuyó la etiología a fenómenos de compresión mecánica provocados por el balón sobre el cuerpo pancreático durante el descanso en decúbito prono. Hacemos notar que el hábito de reposo en la posición decúbito ventral constituiría un potencial factor de riesgo para pancreatitis post-colocación de balón intragástrico, por lo que este factor debe ser tomado en cuenta en la orientación de los candidatos a esta técnica.

show abstract

Section: Discussionunclassified

Pancreatitis aguda asociada a balón intragástrico

Vega

Cabrera-Hinojosa

2023

Rev Gastroenterol Peru

View full text Add to dashboard Cite

show abstract

“…There was a significant improvement in waist circumference and TGs. The early balloon deflation rate was 1.8% (CI: 0.6-5.1) [29]. A cost-effectiveness study investigated the use of the Allurion as a standalone therapy or as a bridge to sleeve gastrectomy in comparison to six other treatment strategies.…”

Section: Allurionmentioning

confidence: 99%

Endoluminal bariatric and metabolic therapies: state-of-the-art

Bakheet

Badurdeen

Sartoretto

et al. 2023

Current Opinion in Gastroenterology

View full text Add to dashboard Cite

Purpose of review The aim of this review is to present the current state of the field, highlight recent developments, and describe the clinical outcomes of these endoluminal bariatric and metabolic procedures. Recent findings The landscape of endoluminal devices and techniques for treating obesity has expanded significantly, with FDA-approved therapies currently available to patients with a body mass index values as high as 50 kg/m2. Although notable advancements have been made in this area, there is a need for further emphasis to be placed on the metabolic improvements resulting from these therapies, in addition to the conventional focus on weight loss outcomes. Some of these procedures are now FDA approved for the treatment of metabolic disease as opposed to weight loss. To achieve the most favorable results, it is imperative that all endoluminal interventions are combined with a moderately intensive diet and lifestyle program lasting at least 12 months. Summary Endoluminal metabolic and bariatric therapy represents a bridge between lifestyle counseling, pharmaceutical interventions, and the most efficacious treatment for obesity, bariatric surgery. By virtue of its minimally invasive approach, this therapy may be an appealing option for patients who are ineligible for, or averse to, bariatric surgery and who have experienced suboptimal outcomes or unable to afford medical treatments. Furthermore, these interventions may be particularly beneficial in the early stages of obesity.

show abstract

“…In the same year another meta-analysis of 7 Elipse balloon-studies, involving 2152 patients was conducted by Ramai et al [ 76 ], with the same disadvantage as the previous one: only Ienca’s study[ 58 ] had 1770 cases, while all other six studies ranged from 12 to 135 cases, with high heterogeneity. The results, however, were quite similar: %TBWL was 12.2% (95%CI: 10.1-14.3, I 2 = 94%) and %EBWL was 49.1% (95%CI: 30.6-67.5, I 2 = 97%).…”

Section: Effectiveness For Body Weight Lossmentioning

confidence: 99%

Six intragastric balloons: Which to choose?

Stavrou¹,

Shrewsbury²,

Kotzampassi³

2021

WJGE

View full text Add to dashboard Cite

Endoscopically placed intragastric balloons (IGBs) have played a significant role in obesity treatment over the last 30 years, successfully bridging the gap between lifestyle modification/pharmacotherapy and bariatric surgery. Since they provide a continuous sensation of satiety that helps the ingestion of smaller portions of food, facilitating maintenance of a low-calorie diet, they have generally been considered an effective and reversible, less invasive, non-surgical procedure for weight loss. However, some studies indicate that balloons have limited sustainable effectiveness for the vast majority attempting such therapy, resulting in a return to the previous weight after balloon removal. In this review we try to summarize the pros and cons of various balloon types, to guide decision making for both the physician and the obese individual looking for effective treatment. We analyzed the six most commonly used IGBs, namely the liquid-filled balloons Orbera, Spatz3, ReShape Duo and Elipse, and the gas-filled Heliosphere and Obalon - also including comments on the adjustable Spatz3, and the swallowable Obalon and Elipse - to optimize the choice for maximum efficacy and safety.

show abstract

Influence of the Elipse Intragastric Balloon on Obesity and Metabolic Profile

Abstract: Supplemental Digital Content is available in the text.

Cited by 18 publications

References 35 publications

Pancreatitis aguda asociada a balón intragástrico

Pancreatitis aguda asociada a balón intragástrico

Endoluminal bariatric and metabolic therapies: state-of-the-art

Six intragastric balloons: Which to choose?

Contact Info

Product

Resources

About